The expression of beta-catenin in non-small-cell lung cancer: a clinicopathological study.
Authors:
- M P LeersMLM P Leers
- M A SulzerMSM A Sulzer
- P H TheunissenPTP H Theunissen
Open Access
- 1 December 1998
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 51 (12) , 891-894
Abstract
AIMS: To investigate the expression of beta-catenin in non-small-cell lung cancer (NSCLC) and its clinical significance. METHODS: 101 patients were surgically treated for NSCLC by lobectomy or pneumectomy with systematic lymph node dissection. Follow up was available in all patients, ranging from 24 to 110 months. Immunostaining of tissue sections from primary tumours and (when present) their lymph node metastases was performed and evaluated using a monoclonal antibody against beta-catenin. Correlations were investigated between beta-catenin immunostaining in primary tumours and E-cadherin immunostaining (data available from a previous study), lymph node stage, and survival. RESULTS: There were significant correlations between scores for beta-catenin immunostaining and E-cadherin immunostaining in primary tumours (p = 0.007), and between the beta-catenin immunostaining score in primary tumours and in their lymph node metastases (p = 0.006). An inverse correlation was found between the beta-catenin immunostaining score in primary tumours and lymph node stage N0, N1, or N2 (p = 0.03). According to the Kaplan-Meier survival estimate, the level of beta-catenin expression in primary tumours was a statistically significant prognostic factor (p = 0.01). CONCLUSIONS: Reduced beta-catenin expression in surgically treated NSCLC is clearly associated with lymph node metastasis and an infavourable prognosis. The existence of a functional relation between E-cadherin and beta-catenin is supported by the results of this clinicopathological study.Keywords
This publication has 11 references indexed in Scilit:
- Cadherin and catenin biology represent a global mechanism for epithelial cancer progression.Molecular Pathology, 1997
- Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosisThe Journal of Pathology, 1997
- Expression of E-cadherin, alpha, beta and gamma-catenin in human colorectal cancer.1997
- Expression of E-cadherin and catenins in invasive mammary carcinomas.1997
- E-cadherin mediated adhesion system in cancer cellsCancer, 1996
- Beta-catenin expression in human cancers.1996
- Regulation of the Invasion Suppressor Function of the Cadherin/Catenin ComplexPathology - Research and Practice, 1996
- Loss of E-Cadherin-Dependent Cell-Cell Adhesion due to Mutation of the β-Catenin Gene in a Human Cancer Cell Line, HSC-39Molecular and Cellular Biology, 1995
- Association of the APC Gene Product with β-CateninScience, 1993
- Mediastinal lymph node dissection in resected lung cancer: Morbidity and accuracy of stagingThe Annals of Thoracic Surgery, 1993